Unauthenticated Access Vulnerability in Oracle Life Sciences Central Coding
CVE-2026-21980

6.5MEDIUM

Key Information:

Vendor

Oracle
Status
Oracle Life Sciences Central Coding
Vendor
CVE Published:
20 January 2026

What is CVE-2026-21980?

An unauthenticated access vulnerability has been identified in Oracle Life Sciences Central Coding, which allows attackers with network access via HTTP to exploit the system. This can lead to unauthorized updates, insertions, or deletions of sensitive data within the affected application. Additionally, the vulnerability facilitates unauthorized read access to certain subsets of accessible data, posing significant risks to data confidentiality and integrity.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Oracle Life Sciences Central Coding 7.0.1.0

References

https://www.oracle.com/security-alerts/cpujan2026.html
vendor-advisory

CVSS V3.1

Score:
6.5
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.